Michelle M. O'donnell
Cork, M, Ireland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
LPA3 agonist-producing Bacillus velezensis ADS024 is efficacious in multiple neuroinflammatory disease models.
Journal: Brain, behavior, and immunity
Published: March 04, 2024
Novel, non-colonizing, single-strain live biotherapeutic product ADS024 protects against Clostridioides difficile infection challenge in vivo.
Journal: World journal of gastrointestinal pathophysiology
Published: June 01, 2023
Identification of ADS024, a newly characterized strain of Bacillus velezensis with direct Clostridiodes difficile killing and toxin degradation bio-activities.
Journal: Scientific reports
Published: October 06, 2021
The Use of a Mini-Bioreactor Fermentation System as a Reproducible, High-Throughput ex vivo Batch Model of the Distal Colon.
Journal: Frontiers in microbiology
Published: May 01, 2018
Preparation of a standardised faecal slurry for ex-vivo microbiota studies which reduces inter-individual donor bias.
Journal: Journal of microbiological methods
Published: April 22, 2016
The Genome of the Predominant Equine Lactobacillus Species, Lactobacillus equi, Is Reflective of Its Lifestyle Adaptations to an Herbivorous Host.
Journal: Genome announcements
Published: January 18, 2014
Catabolic flexibility of mammalian-associated lactobacilli.
Journal: Microbial cell factories
Published: February 14, 2013
Carbohydrate catabolic flexibility in the mammalian intestinal commensal Lactobacillus ruminis revealed by fermentation studies aligned to genome annotations.
Journal: Microbial cell factories
Published: October 15, 2011
Genome sequences and comparative genomics of two Lactobacillus ruminis strains from the bovine and human intestinal tracts.
Journal: Microbial cell factories
Published: October 15, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026